GlassScriptPhysician profile
Joy Johnstone Geter
NPI 1942884440
$3,015.14
in general payments reported to CMS, 2019-2025
22 companies · $15.42 in 2025
The $15.42 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.75 · 2023: $2,011 · 2024: $977 · 2025: $15.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,903 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,903.40 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $667.29 | 2022-2024 | Tezspire, Fasenra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $326.44 | 2023-2024 | Glassia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.22 | 2023-2024 | Ofev |
| Glaxosmithkline, LLC. | $266.81 | 2023-2024 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $192.64 | 2023-2024 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $176.55 | 2023-2024 | Acthar |
| Inari Medical, INC. | $146.44 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $128.09 | 2023-2024 | |
| Amgen INC. | $115.62 | 2023-2024 | Tezspire |
| Mylan Specialty L.P. | $105.69 | 2023-2024 | Yupelri |
| Csl Behring | $92.82 | 2023 | Hizentra |
| Baxter Healthcare | $92.56 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $92.02 | 2023-2024 | (Ak6) Vest Therapy |
| Insmed, INC. | $77.71 | 2023-2024 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $62.13 | 2023-2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $44.14 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $42.94 | 2024 | Uptravi, Opsumit |
| Shionogi INC | $26.62 | 2024 | Fetroja |
| Harmony Biosciences LLC | $19.52 | 2023 | Wakix |
| Merck Sharp & Dohme LLC | $18.93 | 2023 | |
| Genentech USA, INC. | $18.00 | 2023 | Xolair |
| Electromed, INC. | $13.96 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Geter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.